Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 74.12 | 61.84 | 80.65 | 226.74 |
Total Revenue | 74.12 | 61.84 | 80.65 | 226.74 |
Costof Revenue Total | 21.84 | 17.92 | 31.62 | 51.57 |
Gross Profit | 52.28 | 43.92 | 49.03 | 175.17 |
Selling/ General/ Admin Expenses Total | 6.50 | 5.03 | 3.56 | 4.67 |
Depreciation/ Amortization | 1.06 | 0.86 | 0.67 | 0.62 |
Unusual Expense( Income) | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Expenses Total | 12.80 | 9.75 | 8.36 | 20.51 |
Total Operating Expense | 42.20 | 33.55 | 44.22 | 77.37 |
Operating Income | 31.92 | 28.28 | 36.43 | 149.37 |
Interest Inc( Exp) Net- Non- Op Total | -1.24 | -1.98 | -1.06 | -2.28 |
Other Net | 12.53 | 7.23 | 6.90 | 2.89 |
Net Income Before Taxes | 44.33 | 35.31 | 43.22 | 152.04 |
Provisionfor Income Taxes | 12.23 | 9.37 | 11.02 | 38.17 |
Net Income After Taxes | 32.10 | 25.94 | 32.20 | 113.87 |
Minority Interest | 0.63 | 0.15 | - | - |
Net Income Before Extra Items | 32.73 | 26.08 | 32.20 | 113.87 |
Net Income | 32.73 | 26.08 | 32.20 | 113.87 |
Income Availableto Com Excl Extra Ord | 32.73 | 26.08 | 32.20 | 113.87 |
Income Availableto Com Incl Extra Ord | 32.73 | 26.08 | 32.20 | 113.87 |
Diluted Net Income | 32.73 | 26.08 | 32.20 | 113.87 |
Diluted Weighted Average Shares | 0.87 | 0.86 | 0.75 | 0.75 |
Diluted EPS Excluding Extra Ord Items | 37.46 | 30.28 | 42.98 | 152.00 |
DPS- Common Stock Primary Issue | 3.00 | 2.50 | 2.50 | 1.00 |
Diluted Normalized EPS | 37.46 | 30.28 | 42.98 | 152.00 |
3B Blackbio DX Dividend 3B Blackbio DX Bonus 3B Blackbio DX News 3B Blackbio DX AGM 3B Blackbio DX Rights 3B Blackbio DX Splits 3B Blackbio DX Board Meetings 3B Blackbio DX Key Metrics 3B Blackbio DX Shareholdings 3B Blackbio DX Balance Sheet 3B Blackbio DX Cashflow 3B Blackbio DX Q1 Results 3B Blackbio DX Q2 Results 3B Blackbio DX Q3 Results 3B Blackbio DX Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks